SAGE THERAPEUTICS INC shareholders Q3 2023

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 194 filers reported holding SAGE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

SAGE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,149,482$105,976,3402.24%
Palo Alto Investors LP 1,005,776$20,698,8701.96%
Boxer Capital, LLC 1,094,000$22,514,5201.20%
Bellevue Group AG 3,513,351$72,304,7641.16%
PDT Partners, LLC 181,625$3,737,8430.47%
EASTERLY INVESTMENT PARTNERS LLC 195,643$4,026,3330.44%
Harvest Investment Services, LLC 30,302$623,6150.40%
Simplify Asset Management Inc. 120,030$2,470,2170.28%
SAMLYN CAPITAL, LLC 739,867$15,226,4630.25%
CAXTON ASSOCIATES LP 68,035$1,400,1600.19%
HARBOR CAPITAL ADVISORS, INC. 34,773$715,6280.15%
Values First Advisors, Inc. 10,626$218,6930.14%
XTX Topco Ltd 38,093$783,9540.13%
Hennion & Walsh Asset Management, Inc. 85,495$1,759,4870.11%
SEVEN EIGHT CAPITAL, LP 42,632$877,3670.10%
AdvisorShares Investments LLC 16,415$337,8210.09%
Cavalier Investments, LLC 10,028$206,3760.08%
PROFUND ADVISORS LLC 68,755$1,414,9780.08%
Alyeska Investment Group, L.P. 528,821$10,883,1360.07%
Jump Financial, LLC 88,301$1,817,2350.07%
External links

This page lists SAGE THERAPEUTICS INC's shareholders in Q3 2023. To view SAGE THERAPEUTICS INC's shareholder history, click here.